hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma

PHASE2CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

February 29, 2008

Study Completion Date

May 31, 2012

Conditions
Neuroblastoma
Interventions
BIOLOGICAL

hu14.18-Interleukin-2 fusion protein

Given IV

Trial Locations (81)

10595

New York Medical College, Valhalla

15213

Children's Hospital of Pittsburgh, Pittsburgh

24029

Carilion Cancer Center of Western Virginia, Roanoke

29203

Palmetto Health South Carolina Cancer Center, Columbia

32504

Sacred Heart Cancer Center at Sacred Heart Hospital, Pensacola

33407

Kaplan Cancer Center at St. Mary's Medical Center, West Palm Beach

33607

St. Joseph's Cancer Institute at St. Joseph's Hospital, Tampa

35294

Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham, Birmingham

37403

T.C. Thompson Children's Hospital, Chattanooga

37901

East Tennessee Children's Hospital, Knoxville

38105

St. Jude Children's Research Hospital, Memphis

40232

Kosair Children's Hospital, Louisville

44195

Cleveland Clinic Taussig Cancer Center, Cleveland

48910

Breslin Cancer Center at Ingham Regional Medical Center, Lansing

53226

Midwest Children's Cancer Center, Milwaukee

55404

Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis

55455

University of Minnesota Cancer Center at University of Minnesota, Minneapolis

60614

Children's Memorial Hospital - Chicago, Chicago

63110

Siteman Cancer Center at Barnes-Jewish Hospital, St Louis

64108

Children's Mercy Hospital, Kansas City

72205

Arkansas Cancer Research Center at University of Arkansas for Medical Sciences, Little Rock

73104

Oklahoma University Cancer Institute, Oklahoma City

75230

Medical City Dallas Hospital, Dallas

75390

Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas, Dallas

76104

Cook Children's Medical Center - Fort Worth, Fort Worth

78207

University of Texas Health Science Center at San Antonio, San Antonio

79106

Texas Tech University Health Sciences Center School of Medicine - Amarillo, Amarillo

90027

Childrens Hospital Los Angeles, Los Angeles

92868

Children's Hospital of Orange County, Orange

94115

UCSF Comprehensive Cancer Center, San Francisco

94305

Stanford Comprehensive Cancer Center - Stanford, Stanford

95816

Sutter Cancer Center, Sacramento

93638-8762

Children's Hospital Central California, Madera

80218-1088

Children's Hospital Cancer Center, Denver

20010-2970

Children's National Medical Center, Washington D.C.

32610-0232

University of Florida Shands Cancer Center, Gainesville

30912-3730

MBCCOP - Medical College of Georgia Cancer Center, Augusta

60637-1470

University of Chicago Cancer Research Center, Chicago

62794-9620

Southern Illinois University School of Medicine, Springfield

46202-5289

Indiana University Melvin and Bren Simon Cancer Center, Indianapolis

40536-0293

Markey Cancer Center at University of Kentucky Chandler Medical Center, Lexington

71315-3198

Tulane Cancer Center Office of Clinical Research, Alexandria

04401

CancerCare of Maine at Eastern Maine Medial Center, Bangor

02111

Floating Hospital for Children at Tufts - New England Medical Center, Boston

02115

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston

48201-1379

Barbara Ann Karmanos Cancer Institute, Detroit

49503-2560

Spectrum Health Hospital - Butterworth Campus, Grand Rapids

39216-4505

University of Mississippi Cancer Clinic, Jackson

89109-2306

Sunrise Hospital and Medical Center, Las Vegas

03756-0002

Norris Cotton Cancer Center at Dartmouth - Hitchcock Medical Center, Lebanon

07601

Hackensack University Medical Center Cancer Center, Hackensack

07962

Overlook Hospital, Morristown

08903

Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick

87131-5636

University of New Mexico Cancer Research and Treatment Center, Albuquerque

14263-0001

Roswell Park Cancer Institute, Buffalo

27599-7295

Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill

28232-2861

Blumenthal Cancer Center at Carolinas Medical Center, Charlotte

28233-3549

Presbyterian Cancer Center at Presbyterian Hospital, Charlotte

44308-1062

Children's Hospital Medical Center of Akron, Akron

45229-3039

Cincinnati Children's Hospital Medical Center, Cincinnati

43205-2696

Columbus Children's Hospital, Columbus

17822-0001

Geisinger Medical Center, Danville

17033-0850

Penn State Cancer Institute at Milton S. Hershey Medical Center, Hershey

19104-9786

Children's Hospital of Philadelphia, Philadelphia

37232-6838

Vanderbilt-Ingram Cancer Center, Nashville

84113-1100

Primary Children's Medical Center, Salt Lake City

23298-0037

Virginia Commonwealth University Massey Cancer Center, Richmond

99220-2555

Providence Cancer Center at Sacred Heart Medical Center, Spokane

53792-6164

University of Wisconsin Paul P. Carbone Comprehensive Cancer Center, Madison

T3B 6A8

Alberta Children's Hospital, Calgary

T6G 1Z2

University of Alberta Hospital, Edmonton

V6H 3V4

Children's & Women's Hospital of British Columbia, Vancouver

R3E 0V9

CancerCare Manitoba, Winnipeg

B3K 6R8

IWK Health Centre, Halifax

L8N 3Z5

McMaster Children's Hospital at Hamilton Health Sciences, Hamilton

N6A 4G5

Children's Hospital of Western Ontario, London

K1H 8L1

Children's Hospital of Eastern Ontario, Ottawa

M5G 1X8

Hospital for Sick Children, Toronto

H3H 1P3

Montreal Children's Hospital at McGill University Health Center, Montreal

H3T 1C5

Hopital Sainte Justine, Montreal

G1V 4G2

Centre Hospitalier Universitaire de Quebec, Québec

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Children's Oncology Group

NETWORK

NCT00082758 - hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma | Biotech Hunter | Biotech Hunter